Amarin Corp. Plc (AMRN)
12.35
-0.37
(-2.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.38
+0.02
(+0.20%)
After-Hours: 20:00
Amarin Price to Book Value : 0.5847 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.5847 |
| October 01, 2026 | 0.6022 |
| September 30, 2026 | 0.6155 |
| September 29, 2026 | 0.6221 |
| September 28, 2026 | 0.6273 |
| September 25, 2026 | 0.6249 |
| September 24, 2026 | 0.6358 |
| September 23, 2026 | 0.6495 |
| September 22, 2026 | 0.651 |
| September 21, 2026 | 0.6382 |
| September 18, 2026 | 0.6453 |
| September 17, 2026 | 0.6567 |
| September 16, 2026 | 0.6552 |
| September 15, 2026 | 0.6595 |
| September 14, 2026 | 0.6628 |
| September 11, 2026 | 0.6533 |
| September 10, 2026 | 0.6647 |
| September 09, 2026 | 0.6813 |
| September 08, 2026 | 0.6746 |
| September 04, 2026 | 0.6453 |
| September 03, 2026 | 0.6491 |
| September 02, 2026 | 0.6486 |
| September 01, 2026 | 0.6555 |
| August 31, 2026 | 0.6571 |
| August 28, 2026 | 0.6614 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.6661 |
| August 26, 2026 | 0.6806 |
| August 25, 2026 | 0.6699 |
| August 24, 2026 | 0.6552 |
| August 21, 2026 | 0.6671 |
| August 20, 2026 | 0.6656 |
| August 19, 2026 | 0.6808 |
| August 18, 2026 | 0.669 |
| August 17, 2026 | 0.6633 |
| August 14, 2026 | 0.6661 |
| August 13, 2026 | 0.6699 |
| August 12, 2026 | 0.6656 |
| August 11, 2026 | 0.6633 |
| August 10, 2026 | 0.668 |
| August 07, 2026 | 0.6798 |
| August 06, 2026 | 0.6751 |
| August 05, 2026 | 0.6822 |
| August 04, 2026 | 0.6817 |
| August 03, 2026 | 0.6694 |
| July 31, 2026 | 0.6751 |
| July 30, 2026 | 0.6737 |
| July 29, 2026 | 0.6704 |
| July 28, 2026 | 0.6604 |
| July 27, 2026 | 0.6538 |
| July 24, 2026 | 0.6415 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Neurocrine Biosciences, Inc. | 3.938 |
| Alkermes Plc | 3.868 |
| Liquidia Corp. | 13.08 |
| Akari Therapeutics Plc | 0.8208 |
| DBV Technologies SA | 3.003 |
Price to Book Value Related Metrics
| PS Ratio | 1.385 |
| Price to Free Cash Flow | 16.55 |
| Price | 12.35 |
| Earnings Yield | -10.51% |
| Market Cap | 259.38M |